Buys
Open market- Shares
- Avg price
- Total value
Aoife Brennan - President and CEO, Director at Climb Bio, Inc.
Issuer-level insider activity
- Role
- President and CEO, Director
- Issuer ticker
- CLYM on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Aoife Brennan in Climb Bio, Inc.
Sells
Open market- Shares
- -30,902
- Avg price
- $13.17
- Total value
- -$406,979
Net
Past year- Shares
- -30,902
- Share %
- -100%
- Total value
- -$406,979
Reported holdings for Aoife Brennan in Climb Bio, Inc.
Form 4 holding
President and CEO, Director
Climb Bio, Inc.
- Security class
- Restricted Stock Units
- Shares / value
- 137,500
- Estimated value
- $1,983,988
- Report date
- 27 Jun 2026
- Price
- $7.21
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
President and CEO, Director
Climb Bio, Inc.
- Security class
- Common Stock
- Shares / value
- 87,731
- Estimated value
- $1,155,417
- Report date
- 29 Jun 2026
- Price
- $13.17
- Ownership
- Direct
Form 4 holding
President and CEO, Director
Climb Bio, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 700,000
- Estimated value
- Report date
- 06 Jan 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Aoife Brennan in Climb Bio, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.